BioMarin Pharmaceutical | BMRN - 贷款资金

金融业

USD

USD 8.59B

现金及等价物

USD 2.22B

USD 199.48M

USD 4.61B

USD 793.15M

USD 1.44B

USD 129.65M

USD 146.05M

3.04K

EPS每股收益

USD 0.76

股本和储备

USD 6.21B

USD 571.21M

债务利息支出

USD 14.96M

USD 22.56M

USD 1.43B

USD 11.01B

USD 105.53M

USD 636.56M

USD 129.65M

普通股股本

USD 193.27M

15.28

USD 141.2M

USD 766M

销售和管理费用

USD 258.28M

USD 1.27B

贸易债权人

USD 793.15M

应收帐款人

USD 903.91M

	贷款资金	更改		日
Acadia Pharmaceuticals	USD 0		0	2025-03
Agios Pharmaceuticals	USD 1.06M		0	2022-09
Alnylam Pharmaceuticals	USD 2.48B		931K	2026-03
Amgen	USD 51.89B		1.88B	2026-03
Bayer	EUR 30.68B		1.15B	2026-03
Biogen	USD 6.29B		1.7M	2026-03
BioMarin Pharmaceutical	USD 1.43B		833.11M	2026-03
Gilead Sciences	USD 20.86B		1.27B	2026-03
Incyte	USD 29.41M		785K	2026-03
Insmed	USD 542.22M		1.25M	2026-03
Ionis Pharmaceuticals	USD 1.91B		9M	2026-03
Moderna	USD 603M		7M	2026-03
Neurocrine Biosciences	USD 169.5M		500K	2023-03
PTC Therapeutics	USD 286.94M		1.74B	2026-03
Puma Biotechnology	USD 10.87M		222K	2025-06
Regeneron Pharmaceuticals	USD 1.99B		719.7M	2026-03
Roche Holding	CHF 27.43B		966M	2025-12
Sangamo BioSciences	USD 0		0	2022-06
Sanofi	EUR 15.72B		150.06M	2025-12
Sarepta Therapeutics	USD 838.16M		9.19M	2026-03
Ultragenyx Pharmaceutical	USD 1.13B		19M	2026-03
United Therapeutics	USD 100M		100M	2024-06
Vertex Pharmaceuticals	USD 106.7M		4.7M	2025-12